Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jerrold Levy

Anesthesiology Durham, NC Medical Doctor

NPI 1891863429 CMS profile 221623

2100 Erwin Rd, Durham, NC 27705

Open in the dashboard

General payments

$305,017

230 records reported · program years 2019–2025

Research payments

$13,579

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jerrold Levy of Durham, NC is reported in the CMS Open Payments database as having received $305,017 across 230 general payments and $13,579 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $96,106 52
2024 General $48,865 51
2024 Research $6,335 4
2023 General $42,183 24
2023 Research $171 1
2022 General $16,804 15
2022 Research $2,990 2
2021 General $10,994 10
2021 Research $4,083 1
2020 General $20,596 18
2019 General $69,469 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jerrold Levy
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Jerrold Levy were reported at $96,106. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Jerrold Levy Anesthesiology median Middle half National median
2019 $69,469 $72 $23–$151 $163
2020 $20,596 $36 $17–$120 $114
2021 $10,994 $49 $21–$135 $132
2022 $16,804 $52 $22–$144 $149
2023 $42,183 $53 $23–$143 $160
2024 $48,865 $55 $25–$150 $164
2025 $96,106 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CSL Behring $75,556 55 payments
  2. Instrumentation Laboratory Company $58,690 38 payments
  3. Octapharma USA, Inc. $41,670 48 payments
  4. Grifols Shared Services North America, Inc. $26,428 23 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $16,285 1 payment
  6. Merck Sharp & Dohme Corporation $15,540 12 payments
  7. Grifols, S.A. $15,514 6 payments
  8. Boehringer Ingelheim (China) Investment Co., Ltd. $15,259 8 payments
  9. Janssen Research & Development, LLC $11,588 10 payments
  10. Daiichi Sankyo Inc. $8,100 6 payments
  11. Other $20,388 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $120,999 44 payments
  2. Travel and Lodging $91,443 85 payments
  3. Honoraria $52,213 19 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35,171 11 payments
  5. Food and Beverage $5,191 71 payments
Products named General payments · program years 2019–2025
  1. Kcentra $22,821 30 payments
  2. BRIDION $15,540 12 payments
  3. FIBRYGA Intensive Careemergency $15,129 17 payments
  4. FIBRYGA Intensive Careemergency $11,682 22 payments
  5. Thrombate III $9,760 3 payments
  6. BALFAXAR $5,912 3 payments
  7. PRADAXA $4,652 2 payments
  8. FIBRYGA & BALFAXAR $4,500 1 payment
  9. SAVAYSA $4,500 2 payments
  10. RiaSTAP $4,052 3 payments
  11. Other $7,713 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Octapharma USA, Inc. $9,496 7 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $4,083 1 payment

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$29,281

Medicare's payments for the services billed

Medicare patients

59

Average age 66

Services billed

191

25 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 66%
Atrial fibrillation 66%
Diabetes 54%
Chronic kidney disease 53%
Arthritis 32%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $19,730
$19,730 — —
Albutein
  • Grifols, S.A. $3,304
$3,304 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

238 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record